Quantcast
Viewing all articles
Browse latest Browse all 2101

NewAmsterdam hits primary endpoint in CETP inhibitor trial

NewAmsterdam Pharma’s cardio drug succeeded in a third readout this year, showing that obicetrapib could lower a type of lipoprotein that carries cholesterol in the blood. The BROADWAY trial hit on ...

Viewing all articles
Browse latest Browse all 2101

Trending Articles